Ipca Laboratories Ltd (IPCALAB)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 1319.00
% Change: 0.08% (Prev Close: 1318.00)

Volume: 83,745
% Change: -14.70% (Prev Volume: 98,181)

Delivery: 43,187
Delivery % : 51.57
% Change: -14.92% (Prev Delivery: 50,759)

Turnover: 1,104 Lacs
% Change: -15.20% (Prev Turnover: 1,301)

πŸ’Ή EOD Valuation

P/E Ratio: 42.98
P/B Ratio: 4.82
Market Cap: 33463 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: IPCALAB
Market Cap: 35123 Rs. Cr.
Face Value: 1.00 Rs.

52 Week High: 1757.65
52 Week Low: 1168.20

All-Time High: 1757.65 Rs.
All-Time Low: 23.50 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-5.26% | -1.38% | 1.42% | -4.28% | 15.11%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 44.72%

Change (3Y | 1Y): -1.57% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 10.67%

Change (3Y | 1Y): 0.06% | -0.08%

DII Holding

DII Holding: 35.88%

Change (3Y | 1Y): 2.39% | 0.15%

Public Holding: 8.41%

🏦 Financial Strength

Debt to Equity: 0.20
Debt: 1362.74 Rs. Cr.

Book Value: 273.88 Rs.
Current Ratio: 2.18
Interest Coverage: 18.34
Free Cash Flow: 551.13 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: 11.49%

Sales Growth Qtr (YOY | QoQ):
10.33% | 2.77%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
14.01% | 15.35% | 11.49%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: 44.12%

Profit Growth Qtr (YOY | QoQ):
21.31% | 263.95%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
7.24% | -1.48% | 44.12%

EPS Rs.

EPS (TTM): 30.69 Rs.

EPS Qtr (Last Year | Latest):
7.58 Rs. | 9.19 Rs.

EPS Annual (Last Annual | Annual March):
21.57 Rs. | 29.08 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
7.16% | -1.48%

Net Profit Rs. Cr.

Net Profit (TTM): 818.99 Rs. Cr.

Net Profit (Annual - March): 785.24 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
199.14| 63.99 | 232.89

EBITDA Rs. Cr.

EBITDA (Quarter): 449.08 Rs. Cr.
EBITDA (Previous Yr Ql): 413.33 Rs. Cr.

EBITDA (Annual - March): 1789.93 Rs. Cr.
EBITDA (Previous Annual): 1414.65 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
13.33% | 9.03%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 19.11%

OPM Qtr (Previous | Current):
19.09% | 18.04%

OPM Annual (5 Yrs | Last Yr | March):
20.22% | 17.28% | 19.46%

Return on Equity %

ROE: 12.75%

ROE (5 Yrs | 3 Yrs | Last Yr):
14.17% | 10.31% | 9.75%

Return on Capital Employed %

ROCE: 14.72%

ROCE (5 Yrs | 3 Yrs | Last Yr):
17.90% | 12.88% | 12.77%

Return on Assets %

ROA (TTM): 7.89%

ROA (5 Yrs | 3 Yrs | Last Yr):
10.48% | 6.45% | 5.77%

PEG Ratio: -26.53
Dividend Yield: 0.29%

PE 3 Yrs: 46.73
PE 5 Yrs: 36.03

Dividend Yield: 0.29%

πŸ‘₯ Company

Ipca Laboratories Ltd

IPCALAB

Promoter Holding: %